Truth about bribery, corruption risks
I FIRST got to know Richard Bistrong when he contacted me after my commentary in The Business Times on the GlaxoSmithKline (GSK) bribery scandal (“Plausible deniability and graft by MNCs”, BT, May 21, 2014), in which I had quoted from his blog.
Read More









